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1. Introduction 
 
Tissue engineering aims to restore damaged tissues and/or functions in the human body by 
stimulating the physiological mechanism of regeneration and repair. Bioactive glasses (BGs) and 
glass-ceramics (BGCs) have a high potential in the field of regenerative medicine as regards both 
hard-tissue engineering and, more recently, soft-tissue engineering. In the early 1970s, the concept 
of bioactivity was defined as the ability of certain materials to bond to bone and to stimulate 
osteogenesis [1]; since then, BGs began to be proposed and investigated for bone implants 
applications. The first generation of BGs involved silicate-based glasses, in which silicon dioxide 
(SiO2) acts as a network former, and other oxides, such as Na2O, and CaO, were added to the 
composition as network modifiers. Bioglass
®
, belonging to the SiO2–Na2O–CaO–P2O5 system, was 
the first glass able to form an interfacial bond with living bone after implantation [2]. Since then, 
more complex compositions were designed to enhance the bioactivity of the material.   
In the last decade, one of the major challenges of tissue engineering has been the synthesis of 
materials able to safely dissolve once they have performed their function, leaving the body to 
remodel the tissue to its natural form. To this aim a novel group of glasses involving P2O5 as 
network former have been proposed; the asymmetry of the [PO4] tetrahedron unit, that represents 
the phosphate-based glass structural unit, is believed to be the origin of their low durability, 
together with the ease of hydration of the P–O–P bonds  [3]. Phosphate glasses (PGs) have a great 
potential because their solubility is strongly dependent on their composition; their degradation rate 
can be tailored by adding metal oxides, such as TiO2 [4-5], CuO [6] and Fe2O3 [7-8] to the glass 
composition. PGs dissolves congruently throughout the whole process [9]. The two interdependent 
steps that take place during glass dissolution are the hydration reaction, with a Na–H ion exchange, 
and the network breakage in the hydrated layer due to the destruction of the P–O–P bonds [3]. PGs 
have been widely studied as a controlled release vehicle of antibacterial ions, such as silver, copper, 
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zinc, gallium [10] and have been also studied for application in the field of bone tissue regeneration 
in the form of powder or porous scaffold, alone or with polymers in composite materials [4,11].  
Nerve guide of PGs, like tubes or mesh of non-woven fibres, were developed and tested in vivo [12-
13] with good results and 3-D constructs for the repair of the muscular tissue have been also studied 
[14]. 
In this work, a novel phosphate-based glass-ceramic (GC-ICEL) was synthesised and characterized 
in terms of crystalline structure, solubility and biological compatibility. It is known that the events 
occurring at the glass surface, i.e. adsorption of molecules and growth factors, lead to integrin 
activation and cell adhesion [15]. As described for other glass substrates [16], the immersion of GC-
ICEL in α-minimum essential medium (α-MEM) may trigger a continuous ion-exchange between 
the surface and the solution. The aim of the cell-based studies presented in this work was to 
evaluate the effect of GC-ICEL on adhesion, proliferation and gene expression of osteoblastic 
markers of human marrow-derived stromal cells (hMSCs). 
 
2. Materials and Methods 
 
2.1. Synthesis of glass 
 
The starting phosphate-based glass belonged to the P2O5–SiO2–CaO–MgO–Na2O–K2O system 
(ICEL) [17], and had the following molar composition: 45% P2O5, 3% SiO2, 26% CaO, 7% MgO, 
15% Na2O, 4% K2O. ICEL was prepared by melting the raw products, i.e. (NH4)2HPO4, SiO2, 
Ca3(PO4)2, Mg3(PO4)2·8H2O, Na3PO4·12H2O and K2HPO4, in a platinum crucible at 1,200 °C in air 
for 1 h to ensure homogeneity (heating rate set at 10 °C∙min-1). The molten glass was cast into 
moulds to produce bars that were cut by a diamond rotating wheel (Struers Accutom 5). The glass 
pieces were ground by ball milling to obtain powders which were sieved below 30 μm. 
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2.2. Preparation of glass-ceramic samples 
 
Massive glass-ceramic ICEL (GC-ICEL) samples were obtained via uniaxial dry pressing of as-
poured glass powders sieved below 30 μm and by a suitable thermal treatment. Both disk-shaped 
and bar-shaped “green” compacts were produced depending on the end use. Specifically, the disks 
were used for GC-ICEL morphological, structural and in vitro characterization, whereas the bars 
were cut into slices for the biological assessment. Both samples (disks and slices) were produced 
with surface area of ~50 mm
2
 and thickness of ~2 mm. The applied pressure and time were set in 
order to obtain crack-free “greens”; the optimal conditions were identified with 135 MPa/10 s for 
the bars and with 90 MPa/60 s for the disks. The “green” bodies were thermally treated at 610 °C 
for 3 h to sinter ICEL powders (heating and cooling rate were set at 5 and 10 °C∙min-1, 
respectively). The sintering conditions were set on the basis of hot stage microscopy and thermal 
analysis data, reported elsewhere [17], to achieve an effective densification of the samples. 
 
2.3. Evaluation of GC-ICEL solubility 
 
Solubility tests were performed on GC-ICEL disks to evaluate the erosion rate and the dissolution 
kinetics of the material. The study was developed according to the ISO standard [18], by soaking 
the samples for different time frames in 25 ml of three media mimicking, with various 
approximation degrees, the biological fluids: distilled water, Tris-HCl and acellular simulated body 
fluid (SBF) [19]. Specifically, GC-ICEL samples were maintained at 37 °C in polyethylene bottles; 
a refresh of the solutions occurred every 48 h to approximately simulate fluid circulation in the 
human body.  
GC-ICEL solubility was assessed by calculating the weight loss of the samples after 7 days and 1, 
2, 3 months of soaking in the three different media. After soaking the samples were extracted from 
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the solutions, dried at room temperature for 24 h and finally weighted. The per cent weight loss ΛW 
(%) was assessed as     
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where W0 and Ws are, respectively, the scaffold weight before and after soaking. 
As the solubility is affected by the surface area, the weight loss per unit area ΛS (mg∙cm
-2
) was 
assessed as  
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where S (cm
2
) is the external surface exposed to the solution.  
The tests were performed on triplicate samples for every time frame; the reported values of weight 
loss are an average of the acquired data. During soaking, the variations of pH in the solutions, due 
to ion-leaching phenomena, were daily monitored. GC-ICEL samples were investigated before and 
after soaking in distilled water, Tris-HCl and SBF by means of wide-angle (2θ within 10-70°) X-ray 
diffraction (XRD; X’Pert Philips diffractometer with Bragg Brentano camera geometry and Cu Kα 
incident radiation). In addition, the samples underwent scanning electron microscopy (SEM) and 
compositional analysis by using a Philips 525M SEM apparatus equipped with Edax Philips 9100 
for energy dispersive spectroscopy (EDS), to evaluate the modifications occurring on their surface 
owing to erosion phenomena. 
 
2.4. Biological tests 
2.4.1. Sample preparation  
The samples were weighed, in dry conditions, prior to cell seeding and after cell removal at each 
time points, to verify any weight loss during in vitro testing. Sterilization was obtained by soaking 
the samples first in 70% ethanol (2 h) and then in 1% antibiotic/antimycotic in phosphate-buffered 
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saline (PBS) (2 h). Finally, a pre-wetting step in 10% serum-added medium (1.5 h) was performed 
to improve cells adhesion. 
2.4.2. Cell isolation  
hMSCs were isolated from bone marrow tissue during total hip replacement surgery. Written 
consent from patients was obtained, and the tissue collection was approved by the Institutional 
Ethical Committee. Heparinized femoral-shaft marrow was layered onto Ficoll gradient and 
mononuclear cells (MNCs) were collected at the interface after centrifugation at 4000×g for 0.5 h. 
MNCs were plated in polystyrene flasks and incubated with α-MEM, 10% foetal bovine serum, 2 
mM glutamine and 1% antibiotic (penicillin/streptomycin) solution (standard medium) at 37°C in 
5% CO2, and non-adherent cells were removed after 4 days. Adherent hMSCs were sub-cultured 
with standard medium added with 50 μg∙ml-1 ascorbate-2 phosphate and splitted at sub-confluence. 
Second passage cells were used for GC-ICEL experiments. 
2.4.3. Cell seeding and culture 
Cells were seeded at a density of 2.5∙104 cells∙cm-2 by applying 25 μl of cell suspension to the 
samples and incubated at 37 °C for 1 h in wet chamber to allow for cell attachment; then 1 ml of 
medium was added to fill the well. hMSCs, seeded in tissue culture plastic (TCPS) at 2.5∙104 
cell∙cm-2 in 24-well plates, provided the controls. Cell seeding efficiency, that is the number of 
attached cells expressed as percent of the cells seeded, was calculated 24 h after plating using 
Picogreen assay; the mean DNA content of our cells was defined by interpolation of the values on a 
reference curve. Then the number of cells was calculated from the Picogreen test results. Cells were 
fed twice a week with osteogenic medium, i.e. standard medium plus 10
-8
 M dexamethasone and 10 
mM β-glycerophosphate. At 1, 7 and 14 days, morphological, biochemical and molecular assays 
were performed. 
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2.4.4. Morphological assays 
Cell morphology of hMSCs on TCPS was monitored by light microscopy throughout the culture 
period. In order to investigate cell morphology and spreading on samples, hMSC were stained with 
two different dyes and observed by fluorescence microscopy (Nikon). Cytoskeleton was visualized 
following staining of actin filaments with rhodamine-phalloidin fluorochrome. Cells fixed with 2% 
paraformaldehyde were permeabilized with 0.5% Triton X-100. Then, the cells were incubated for 
45 minutes at room temperature in the dark with rhodamine-phalloidin 1:200 in PBS (0.06 µM, 
Molecular Probes, Eugene, OR). For acridine orange staining, following fixation in 3.7% 
paraformaldehyde and permeabilization with 0.1% Triton-X100, the cells were incubated with 6 
μg∙ml-1 acridine orange in EDTA-buffer. Ultrastructural analysis was carried out by SEM after the 
cell-seeded samples were treated as already described [20]. 
2.4.5. Biochemical assays 
The pH of supernatant covering the cell-seeded slices was measured 3 times a week by using 
colorimetric stripes (range 6.0-8.0, Merck). Alamar Blue test (Biosource International-CA) was 
used to asses cell viability. Briefly, Alamar Blue solution was added (10%vol.) to the culture wells. 
After incubation for 4 h at 37 °C the medium was transferred in another plate and the fluorescence 
measured using a CytoFluor 2350 plate reader (Millipore Corporation, Bedford, MA, USA) with 
490/530 nm of excitation/emission wavelength. Results were expressed as RFUs (Relative 
Fluorescence Units) normalized to the number of cells seeded. 
DNA content was quantified by Picogreen assay (Quant-IT Picogreen dsDNA, Invitrogen): cells 
were lysed with 0.01% SDS and sonication, and 10 μl of cell lysate or standard were mixed with 10 
μl of Picogreen solution in wells of a 96-well plate. The fluorescence was read at 480-520 nm with 
Cytofluor. 
Alkaline phosphatase (ALP) activity was measured by a chromogenic assay based on conversion of 
p-nitrophenyl phosphate substrate to p-nitrophenol. ALP reaction buffer was added 1:1 to cell 
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lysates and the mixture incubated at 37 °C for 15 minutes. The absorption was measured at 405 nm 
with a spectrophotometer for microplates (Spectra III, Tecan, Austria), and phosphatase activity 
calculated using a calibration curve by serial dilution of p-nitrophenol standard solution. ALP 
activity was normalized to the DNA content, used as an index of the cell number. 
Synthesis of type I collagen was assessed by measuring its metabolic product released in the 
supernatant. Levels of C-terminal propeptide of type I collagen (CICP) were quantified by enzyme 
immunoassay according to the manufacturer’s instructions (Quidel corporation, Heidelberg, 
Germany). 
 
2.4.6. Molecular assay: gene expression analysis 
The gene expression analysis was performed at 24 h (only on control cells), 7 days and 14 days, by 
quantifying the transcripts of genes useful to monitor the hMSCs differentiation to osteoblasts,  as 
reported in Table 1. RNA was extracted with an RNeasy mini kit (Qiagen, GmbH, Hilden, 
Germany) and the retrotranscription was performed with MuLV Reverse Transcriptase (Applied 
Biosystems, Foster City, CA, USA). For real time polymerase chain reaction 1.5 μg of cDNA were 
amplified with the Light Cycler instrument and the Universal Probe Library system (Roche Applied 
Science, Monza, Italy) [21]. Probes and primers were selected using a web-based assay design 
software [ProbeFinder, https://www.roche-applied-science.com]. The results were expressed as a 
ratio between gene of interest and GAPDH reference gene. 
2.4.7. Statistics 
Results are reported as mean ± standard error of three separate experiments on duplicate samples 
and controls.. Differences in gene expression, DNA, and ALP content were assessed using analysis 
of variance (Kruskal-Wallis test); Mann–Whitney test was performed as a post hoc test of the 
multiple analyses, or as unpaired comparison for 2 independent variables. The level of statistical 
significance was established at p < 0.05. 
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3. Results 
 
3.1. GC-ICEL 
As-poured ICEL is a completely amorphous glass, as assessed in a previous work [17]. XRD 
spectra of GC-ICEL before and after soaking in water, SBF and Tris-HCl were compared in figure 
1. The thermal treatment of sintering led to the nucleation of two crystalline phases whose main 
peaks were marked in the XRD pattern. Specifically, the two phases were identified as 
Na2Mg(PO4)3 (sodium/magnesium phosphate, PDF reference code 00-022-0477) and Ca2P2O7 
(calcium pyrophosphate, PDF reference code 00-033-0297).  
After soaking for 7 days in the three different media, a partial dissolution of Na2Mg(PO4)3 crystals 
occurs, as confirmed by the disappearance of the peaks at 2θ = 17.9° and at 2θ = 19.2° identifying 
this phase. Moreover, the intensity of the other peaks associated to this phase progressively 
decreases as the soaking time increases. After 3 months of soaking in water and Tris-HCl, this 
phenomenon is clearly evident. Concerning the samples soaked for 3 months in SBF, a different 
behaviour was observed. The peaks corresponding to GC-ICEL crystalline phases are masked by a 
newly formed phase, which exhibits a main broad peak at 2θ ≈ 32° and was identified as apatite-
like.  
SEM analysis was performed on GC-ICEL before and after soaking in water and in SBF, in order to 
evaluate the modifications occurring in the samples. Figure 2a shows as-done GC-ICEL surface at 
low magnification. A diffuse microporosity, due to the sintering process, can be seen. In figure 2b 
the glass-ceramic nature of the sample is clearly visible, as assessed by XRD data previously 
reported (figure 1). Compositional analysis assessed that the needle-shaped crystals, particularly 
evident in figure 2b, belong to calcium pyrophosphate (Ca2P2O7).  
The surface of GC-ICEL soaked for 7 days in distilled water is depicted in figure 3: a lot of pits can 
be seen due to the high surface erosion rate in water and to the dissolution of the residual 
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amorphous phase. Similar surface modifications and erosions was found on the samples soaked in 
Tris-HCl. GC-ICEL surface after 3 months in SBF is shown in figure 4; globe-shaped agglomerates 
of a newly formed phase are clearly distinguishable. EDS compositional analysis (not reported) 
revealed that this phase is constituted by Ca and P, thus demonstrating the formation of an apatite-
like layer on GC-ICEL surface and confirming the results of XRD investigations (figure 1b). In 
addition, the newly formed phase exhibits a “cauliflower” morphology very similar to that of 
hydroxyapatite (HA) formed on bioactive glasses. 
The weight losses calculated by solubility tests are reported in table 2. A more immediate 
evaluation of weight loss trend is reported as bars chart in figure 5. As expected, the erosion rate in 
the three media increases over the time, due to the progressive release of phosphates in the 
solutions. The highest dissolution is obtained in water, where the weight loss is almost  50% after 3 
months. GC-ICEL shows a weight loss of about 30% in Tris-HCl and of about 10% in SBF after 3 
months. For the GC-ICEL soaked in SBF there is an evident decrease in the weight loss rate after 
the first month. The pH changes are remarkable for the dissolution test in water (variation between 
5.20 and 7.60) and are more moderate in Tris-HCl (variation between 7.30 and 7.50) and in SBF 
(variation between 7.35-7.45). 
 
3.2. Biological tests 
 
3.2.1. GC-ICEL/medium interactions 
The pH of the culture medium was measured to check if ions released by GC-ICEL affect the 
optimal culture condition. It has been found that the pH was not significantly altered in hMSC-
seeded samples: the values, ranging between 6.8 and 7.1 during the 2 weeks-culture period, were 
well tolerated by the cells (figure 6). Regarding sample degradation in the culture medium, after 2 
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weeks of culture GC-ICEL slices had lost 5.2 % of their initial weight, with most of this loss 
occurring in the first 24 h after cell seeding. 
3.2.2. Cell adhesion at early time point 
The seeding efficiency on GC-ICEL slices was 33.8% ± 6.2%. At the early time-point hMSCs were 
observed to attach on the material surface, even if they are not yet completely elongated and 
spindle-shaped, and actin cytoskeleton, highlighted by TRITC-labelled phalloidin staining, is not 
yet organized (figure 7a,b). Cells on TCPS spread with elongated stress fibers (figure 7c,d). 
Ultrastructural analysis by SEM showed anchoring processes extended from cells and confirmed 
that, at 1 day from seeding, hMSCs are able to attach to the surface, as well as surround macropores 
and establish intercellular contacts (figure 8a,b). 
 
3.2.3. Cell viability and proliferation 
The viability of hMSCs grown on GC-ICEL slices was good. GC-ICEL did not altered the 
proliferation rate of hMSCs, that increased their metabolic activity progressively along the whole 
culture time period (figure 9a). The DNA content of control cells became higher along the culture, 
as well. On the contrary, DNA of hMSCs on samples raised during the first 7 days and then stopped 
to augment and, at 14 days, returned to the initial value (figure 9b). 
The values of quantitative parameters for cell number were found to be significantly higher on 
TCPS compared to the same time point on GC-ICEL surfaces, as expected from seeding efficiency 
results. 
The ultrastructural details of GC-ICEL were observed with or without cells (figure 10), and, as it 
can be observed, the pre-wetting treatment with serum did not alter the material surface, apart from 
the already assessed bioerosion process dissolving preferentially the residual amorphous phase and 
the Na2Mg(PO4)3 crystals. At 7 days the cells are more elongated compared to the 1-day view, grow 
in clusters, and  cytoplasmic prolongations are firmly attached to glass-ceramic asperities (figure 
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10c-d). At 14 days of culture on GC-ICEL samples the hMSCs were not confluent, and their 
number was just slightly increased compared to 7 days: this confirms the biochemical data 
indicating that cells are quiescent between the 1
st
 and 2
nd
 week of culture (figure 10e,f). 
 
3.2.4. Osteogenic differentiation 
The alkaline phosphatase activity, marker of early osteogenic differentiation, decreased over time; 
while on TCPS the more significant decrease occurred between 1 and 7 days, in hMSCs grown on 
GC-ICEL, ALP was stable in the 1
st
 week and diminished dramatically from 7 to 14 days (figure 
11a). hMSCs cultured on GC-ICEL were able to produce type I collagen and the amount increased 
progressively along the culture period (figure 11b). Cells grown on TCPS as controls showed a 
similar behaviour over time, with a statistical significant increase from 24 h to 7 days. 
Concerning gene expression, the RNA yield was lower than expected, possibly due to GC-ICEL ion 
release interfering with the procedure of RNA extraction (based on ion exchange). As a 
consequence, due to the low amount of transcripts, some results were close to the detection limit of 
the assay, and not always included in the analysis (figure 12). Expression of ALP transcript 
mirrored the protein activity and slightly decreased in samples and controls, even if the differences 
were not statistically significant, owing to the quite large standard errors of the means. Collagen 
type I gene expression showed a similar behaviour and the descendant trend was observed along the 
culture time. Finally, osteocalcin, late marker of osteodifferentiation, increased steadily from 1 to 
14 days from seeding. Differently from the other assays, the absolute values of transcripts in cells 
grown on GC-ICEL were similar or higher than TCPS controls. 
 
4. Discussion 
 
ICEL is a phosphate-based glass developed by modifying the chemical composition of a silicate-
based glass (CEL2) previously proposed and investigated [22] by the authors. The molar amounts 
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of SiO2 and P2O5 in the ICEL composition are inverted in comparison with those of CEL2, aiming 
to prepare a phosphate-based glass with small amounts of silica, without any variation both of the 
modifier oxides amounts and of the former/modifier oxides ratio, in respect to a well investigated 
composition.  
The presence of SiO2 in ICEL composition was thought to increase the glass degradation rate: in 
fact, as reported by other authors [23], low amount of SiO2 locally disrupts the P2O5-based network 
of the glass. In addition, it was demonstrated that silicon ions stimulate gene expression of 
osteoblasts in order to accelerate bone mineralization [24-26]: this can promote the in vivo 
formation of a stable interface between the glass and the surrounding living bone. 
As shown in figure 1a, the sintering treatment induced the nucleation of two crystalline phases; in 
particular, calcium pyrophosphate (Ca2P2O7) is known to be highly biocompatible and bioactive 
because, as previously reported by other authors [27,28], it can act as precursor of HA or apatite-
like phases mimicking bone mineral. The role of  (Ca2P2O7) showed to be effective in imparting 
bioactive properties to GC-ICEL by promoting the precipitation of a thick HA layer on the GC-
ICEL after soaking in SBF (figure 4). The assessed GC-ICEL bioactivity was in good accord with 
that reported by Monem et al. [29], who observed in vivo bone growth between phosphate glass-
ceramic particles implanted into rabbit femur due to the presence of β-Ca2P2O7 as the main phase. 
Furthermore,  Sun et al. [30] showed that the ionic product derived by the calcium pyrophosphate 
dissolution is able to activate genes of the bone cells and thus the presence of a pyrophosphate 
phase in GC-ICEL could be of particular interest for its application in bone tissue engineering. 
As regards the solubility of GC-ICEL, reported as bar charts in figure 5, some conlcusions can be 
drawn. The weight losses of the samples soaked in SBF are lower than those of the samples soaked 
in water and Tris-HCl, because the formation of a HA layer greatly balances the weight loss due to 
erosion. Hence, it should be noticed that the weight losses in SBF are remarkably underestimated. 
The presence of newly formed HA agglomerates was expected to affect the GC-ICEL dissolution in 
SBF: specifically, the hydrolysis of the phosphate chains was hampered as the precipitated HA 
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layer can act as a diffusion barrier of water molecules, that will reach the GC-ICEL surface in lower 
amounts and at lower rate. The precipitation of a thick HA layer and its barrier diffusion effect can 
explain the drastic decrease in the weight loss rate of GC-ICEL after the first month of soaking in 
SBF. However, the overall rate of dissolution is higher than that of HA precipitation, leading to a 
net weight loss. The GC-ICEL solubility in Tris-HCl is higher than that in SBF, but definitely lower 
than that in distilled water, in which the maximum dissolution rate was observed. These results are 
consistent with XRD and SEM investigations: in fact, both in Tris-HCl and in water no 
precipitation of HA occurred and, therefore, the weight loss was not counterbalanced. 
The pH lowering in distilled water is caused by the release of the acid dissolution product of GC-
ICEL, although the medium was refreshed every 48 h. In SBF and Tris-HCl, which are buffer 
solutions, this phenomenon is almost avoided. Since the dissolution process of phosphate glasses is 
very sensitive to pH [3], the solubility is higher in distilled water than in Tris-HCl and SBF.  
As GC-ICEL is a glass-ceramic material, apart from the congruent dissolution of the residual 
amorphous phase, the two crystalline phases showed a very different behaviour. In fact XRD results 
(reported in figure 1) showed the dissolution of the sodium/magnesium phosphate (Na2Mg(PO4)3) 
phase, while any significant difference was observed in the diffraction peaks of the calcium 
pyrophosphate (Ca2P2O7). This is due to the low solubility of this phase, as reported by other 
authors [27]. 
The tests carried out to assess the biological compatibility of GC-ICEL demonstrated that the 
material is not toxic for human marrow-derived cells, which showed a time-dependent proliferation 
on its surface over a 14-days period. Collagen and ALP production confirm that hMSCs cultured 
with the osteogenic inducers on GC-ICEL substrates go toward bone differentiation. The apparent 
contrast between the results of the viability test and the DNA content may be due to the formation 
on the GC-ICEL surface of an extracellular matrix which restricts cell proliferation to stimulate 
differentiation. This hypothesis, which is also suggested by other authors in a study on bioactive 
glass particles and osteoblasts [31], is supported by the decrease of ALP between 7 and 14 days, 
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whereas collagen steadily increase in the same period, to provide the main structural component of 
extracellular matrix (ECM). In such a condition, the cells remain metabolically active, thus 
converting Alamar blue to formazan deposits, but most of the quiescent cells are entrapped within 
the matrix and can not be easily removed from the surface. As a consequence of these effects, DNA 
measured in the cell lysate is reduced at the final endpoint. It has to be noticed that Augst et al. 
found a similar time-course of DNA production between 3 and 6 weeks in human mesenchymal 
stem cells cultured under continuous osteogenic induction in the bone region of an osteochondral 
composite, despite the condition of dynamic culture obtained with a bioreactor [32]. The decrease 
of ALP activity during culture on a bioactive glass has been observed by Jones et al. [33], who 
found a peak of ALP released by osteoblasts on a phosphate-free bioactive glass at 14 days, to be 
followed by a decrease at 21 days. A production of collagen type I by GC-ICEL seeded cells higher 
than that recorded by TCPS-seeded cells was found, too, by the same Authors. At RNA level, ALP 
transcript decreased, in agreement with ALP enzyme activity, while collagen type I gene expression 
diminished whereas protein expression was enhanced. This can be due to different half-life of the 
targeted protein compared with the respective mRNA: the protein might still be present, while the 
RNA has already been degraded [34]. The gene expression pattern of ALP, collagen I and 
osteocalcin, markers of osteogenic differentiation, suggested that hMSCs grown on GC-ICEL 
reached a late differentiation in the 14 days culture, as cells on TCPS did, confirming that they 
retain their bone-forming potential [35]. 
In summary, concerning the interaction of GC-ICEL and cells, following initial adhesion and some 
proliferation the human marrow stromal cells did not reach confluency on the glass surface. 
Different mechanisms for this behavior may be suggested, including rapid changes of the surface 
chemistry, as described in the soaking assays, which may hamper cell proliferation, or partial 
degradation of the outer layer due to frequent changes of the medium, or an unfavourable 
topography of the glass surface. The formation of an apatite-like layer, which could have been 
osteconductive, was shown after 3 months in SBF; hence, during in vitro culture the cells were 
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likely to grow on a different  substrate. Nonetheless, under osteogenic stimulus, the human marrow 
stromal cells on GC-ICEL differentiated to osteoblast lineage, as shown by ALP and collagen type I 
production, as well as gene expression for ALP, collagen I and osteocalcin. 
 
5. Conclusions 
 
GC-ICEL showed to be bioactive when soaked in a simulated body fluid as the precipitation of a 
continuous layer of HA was observed; this is probably due to the bioactive role of Ca2P2O7 crystals. 
GC-ICEL is a resorbable glass-ceramic showing a continuous dissolution of the residual amorphous 
phase and a preferential dissolution of the Na2Mg(PO4)3 crystals. Combining molecular and 
biochemical analysis, it may be suggested that, on GC-ICEL slices, a stimulation of hMSCs 
differentiation over proliferation occurred. Finally, the presence of a higher expression of bone 
related genes in cells cultured on GC-ICEL compared to cells on TCPS, confirmed the bioactivity 
of this phosphate-based glass-ceramic, and might have a stimulatory effect toward osteogenesis. 
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Tables 
 
Table 1  
List of primers and probes selected to analyse the expression of genes related to the bone cell 
differentiation. 
Gene (Symbol) -  
NCBI reference number 
 Primer sequence (5’-3’) Probe Detection 
limit (μg) 
Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) - 
NM_002046.3 
Sense 
Antisense 
agccacatcgctcagacac 
gcccaatacgaccaaatcc 
#60 3×10
-12
 
Alkaline phosphatase (ALPL) -  
NM_000478.3 
Sense 
Antisense 
gggtcagctccaccacaa 
gcattggtgttgtacgtcttg 
#52 2.1×10
-11
 
Osteocalcin (BGLAP) -  
NM_199173.2 
Sense 
Antisense 
ggcgctacctgtatcaatgg 
tcagccaactcgtcacagtc 
#1 4×10
-12
 
Type 1 collagen, alpha 1 chain (COL1A1) 
- NM_000088.3 
Sense 
Antisense 
cccctggaaagaatggagat 
aatcctcgagcaccctga 
#60 3.7×10
-13
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Table 2  
Weight losses of GC-ICEL samples after soaking in SBF, Tris-HCl and water.  
Soaking medium Weight losses 
Soaking time 
7 days 1 month 2 month 3 month 
SBF 
ΛW (%) 4.2  0.6 10.5  0.6 11.0  1.0 12.0  1.2 
ΛS (mg∙cm
-2
) 8.0  0.9 21.3  1.4 22.6  2.0 25.0  1.1 
Tris-HCl 
ΛW (%) 6.1  0.2 15.9  1.2 28.0  0.3 30.0  1.4 
ΛS (mg∙cm
-2
) 12.0  0.1 30.2  2.0 53.6  2.0 63.1  2.0 
Water 
 
ΛW (%) 29.0  2.0 47.0  1.6 48.0  0.3 49.0  1.5 
ΛS (mg∙cm
-2
) 55.7  1.8 76.5  1.5 93.5  2.0 97.3  2.0 
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Figure  
 
Fig. 1. Diffraction pattern of GC-ICEL after soaking in different aqueous media for 1 week (a) and 
3 months (b). 
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Fig. 2. Micrographs of as-done GC-ICEL at different magnifications: (a) image at 50x, (b) image at 
300x. 
 
 
Fig. 3. GC-ICEL surface after 7 days in water (magnification: 350x). 
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Fig. 4. GC-ICEL surface after 7 days in SBF (magnification: 10,000x). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 26 
Fig. 5. Weight loss of GC-ICEL after soaking in distilled water, Tris-HCl and SBF: assessment of 
(a) ΛW and (b) ΛS. 
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Fig. 6. Variations of medium pH during the cell culture period. 
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Fig. 7. Cell adhesion at 24 h from seeding: cell morphology by acridine orange (a,b) and 
cytoskeleton by phalloidine-TRITC (c,d) of cells grown on GC-ICEL (a,c) and TCPS (b,d). 
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Fig. 8. Cell adhesion at 24 h from seeding: SEM images of cells on GC-ICEL surfaces.  
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Fig. 9. Viability by Alamar test (a) and proliferation by Picogreen test (b) of hMSC on GC-ICEL 
substrate at different time points (RFU= Relative Fluorescence Units). * p < 0.05 on TCPS 1d vs 7d 
(a,b) and 7d vs 14d (a) 
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Fig. 10. SEM analysis of GC-ICEL after pre-wetting treatment (a,b), at 7 days (c,d) and at 14 days 
(e,f) of culture with hMSCs.  
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Fig. 11. Osteogenic differentiation markers: alkaline phosphatase activity from lysate (a) and 
collagen I release in the culture supernatant (b). * p < 0.05 on TCPS 1d vs 7d (a,b) and on GC-ICEL 
7d vs 14d (a). 
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Fig. 12. Gene expression analysis of hMSCs cultured on GC-ICEL. 
 
 
